Skip to content

Local Anesthetic Concentration and Rebound Pain

Evaluation of the Effect of Local Anesthetic Concentration on Rebound Pain After Interscalene Block for Shoulder Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04457557
Enrollment
60
Registered
2020-07-07
Start date
2020-07-10
Completion date
2023-07-31
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rebound Pain

Brief summary

The rebound pain after nerve block could interfere with patient's recovery and rehabilitation. It is not known how local anesthetic concentrations affect rebound pain. The aim of this study is evaluation of the effect of local anesthetic concentration on rebound pain after interscalene block for shoulder surgery.

Detailed description

Shoulder surgery is related to more than moderate pain after surgery. Interscalene nerve block could reduce the postoperative pain effectively. When the effect of nerve block ends, however, rebound pain could appear. The rebound pain could interfere with patient's recovery and rehabilitation. The mechanism of rebound pain is not well known. One of possible mechanism is that the pain stimulus that was blocked suddenly comes out, and it is perceived as more severe pain. The strength of the block may vary depending on the concentration of the local anesthetic. Therefore, the concentration of local anesthetics could affect rebound pain. The aim of this study is evaluation of the effect of local anesthetic concentration on rebound pain after interscalene block for shoulder surgery.

Interventions

OTHERReduced concentration of local anesthetic (ropivacaine)

Reduced concentration of ropivacaine We usually use 0.5% ropivacaine in our facility. The intervention group used 0.15% ropivacaine 15 ml

OTHERUsual concentration of local anesthetic (ropivacaine)

0.5% ropivacaine 15ml

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Only investigator who prepared the local anesthetics knows the group. Nerve block performer and outcome assessor are applied masking.

Intervention model description

Randomized controlled trial One group received interscalene block with 0.15% of ropivacaine One group received interscalene block with 0.5% of ropivacaine

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Elective shoulder surgery under general anesthesia and interscalene block for postoperative pain

Exclusion criteria

* Contraindication of interscalene block: pulmonary disease, lung resection history, brachial nerve injury * Diabetic neuropathy * Adverse drug reaction history to ropivacaine, fentanyl * Impaired coagulation

Design outcomes

Primary

MeasureTime frameDescription
Rebound pain score48 hours after surgeryIt is calculated by subtracting the visual analogue scale (VAS) of pain at the last time when the nerve block was effective from the highest VAS for 12 hours from the time when the nerve block effect disappeared. VAS of pain: 0=no pain \ 10=very severe pain

Secondary

MeasureTime frameDescription
total postoperative fentanyl dose48 hours after surgeryTotal dose of fentanyl injected (mcg) through patient controlled analgesia (PCA) for 48 hours after surgery
fentanyl bolus injection time48 hours after surgeryNumber of bolus injection times using patient controlled analgesia (PCA)
Subjective satisfaction48 hours after surgeryPatient's subjective satisfaction 48 hours after surgery Use visual analogue scale (0=very unsatisfied, 10= very satisfied)

Countries

South Korea

Contacts

Primary ContactIn Kyong Yi, MD
lyrin01@gmail.com+82-31-219-7522

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026